BILIARY TRACT CANCER
Clinical trials for BILIARY TRACT CANCER explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CANCER trials appear
Sign up with your email to follow new studies for BILIARY TRACT CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bile duct cancer patients who have run out of options
Disease control Not yet recruitingThis study tests a new drug called BL-B01D1 against standard treatments in about 538 people with advanced bile duct cancer that has worsened after chemotherapy and immunotherapy. The goal is to see if the new drug helps people live longer. Participants must be 18 to 75 years old …
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
New triple therapy targets hard-to-treat bile duct cancer
Disease control Not yet recruitingThis study tests a combination of three drugs (disitamab vedotin, lenvatinib, and a PD-1 inhibitor) in 65 adults with advanced HER2-positive bile duct cancer that cannot be removed by surgery. The goal is to see how well the treatment shrinks tumors and how safe it is. Participan…
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New drug combo aims to stop bile duct cancer from coming back
Disease control Not yet recruitingThis study tests whether a combination of two drugs, adebrelimab and S-1, can help prevent bile duct cancer from returning after surgery. About 40 adults who had their cancer completely removed will receive the treatment for several months. Researchers will track how many stay ca…
Matched conditions: BILIARY TRACT CANCER
Phase: PHASE2 • Sponsor: Xingjun Guo • Aim: Disease control
Last updated May 07, 2026 18:42 UTC